Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mast cell activation is associated with post-acute COVID-19 syndrome.
Wechsler JB, Butuci M, Wong A, Kamboj AP, Youngblood BA. Wechsler JB, et al. Among authors: youngblood ba. Allergy. 2022 Apr;77(4):1288-1291. doi: 10.1111/all.15188. Epub 2021 Dec 3. Allergy. 2022. PMID: 34820848 Free PMC article. No abstract available.
The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity.
Pyatilova P, Ashry T, Luo Y, He J, Bonnekoh H, Jiao Q, Moñino-Romero S, Hu M, Scheffel J, Frischbutter S, Hermans MAW, Youngblood BA, Maurer M, Siebenhaar F, Kolkhir P. Pyatilova P, et al. Among authors: youngblood ba. Front Immunol. 2022 Jul 26;13:930945. doi: 10.3389/fimmu.2022.930945. eCollection 2022. Front Immunol. 2022. PMID: 35958589 Free PMC article.
AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice.
Youngblood BA, Brock EC, Leung J, Falahati R, Bryce PJ, Bright J, Williams J, Shultz LD, Greiner DL, Brehm MA, Bebbington C, Tomasevic N. Youngblood BA, et al. Int Arch Allergy Immunol. 2019;180(2):91-102. doi: 10.1159/000501637. Epub 2019 Aug 9. Int Arch Allergy Immunol. 2019. PMID: 31401630 Free PMC article.
Lirentelimab for severe and chronic forms of allergic conjunctivitis.
Anesi SD, Tauber J, Nguyen QD, Chang P, Berdy GJ, Lin CC, Chu DS, Levine HT, Fernandez AD, Roy N, Asbell PA, Kantor AM, Chang AT, Singh B, Youngblood BA, Jeng BH, Jhanji V, Rasmussen HS, Foster CS. Anesi SD, et al. Among authors: youngblood ba. J Allergy Clin Immunol. 2022 Sep;150(3):631-639. doi: 10.1016/j.jaci.2022.03.021. Epub 2022 Apr 4. J Allergy Clin Immunol. 2022. PMID: 35390403 Free article. Clinical Trial.
41 results